• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Person › Details

Jutta Fritz (Kinaxo Biotechnologies GmbH)

Fritz, Jutta (Kinaxo 200901– Head Business Development before Max Planck Innovation)

 

	Organisation	Kinaxo Biotechnologies GmbH
	Group	Evotec (Group)
	Former/major organisation	Max Planck Innovation GmbH
	Group	Max Planck Society for the Advancement of Science
	Product	KinAffinity® kinase inhibitor profiling services
	Product 2	PhosphoScout® technology

Kinaxo Biotechnologies GmbH. (10/11/10). "Press Release: Kinaxo Enters Agreement with Bristol-Myers Squibb Company". Martinsried.

KINAXO Biotechnologies GmbH announced today that Bristol-Myers Squibb Company (NYSE:BMY) has chosen KINAXO to support several of its drug discovery programs. Under the terms of the agreement, KINAXO will apply its chemical proteomics technologies to deconvolute molecular targets of compounds currently undergoing discovery research at Bristol-Myers Squibb to enable more informed decisions at various stages of the drug discovery process, such as selecting the right compound for clinical development.

Dr Jutta Fritz, Head of Business Development at KINAXO commented: "We are very pleased to collaborate with Bristol-Myers Squibb, one of the most prestigious pharmaceutical companies in the world. We are looking forward to building a productive partnership with Bristol-Myers Squibb, and consider this move to be a major milestone in expanding our business in the United States."


About KINAXO

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. KINAXO's technology platform offers solutions for drug mode-of-action analysis, cellular target profiling, target deconvolution, drug repositioning and biomarker discovery. KINAXO maintains several collaborations with global pharmaceutical companies, such as Johnson & Johnson, Daiichi-Sankyo, Bayer, Roche and Boehringer Ingelheim. For more information, please visit www.kinaxo.com.

Record changed: 2011-11-25

More documents for Jutta Fritz

• [1] Kinaxo Biotechnologies GmbH. (1/5/11). "Press Release: Kinaxo Enters Agreement with AstraZeneca". Martinsried....
• [2] Kinaxo Biotechnologies GmbH. (10/11/10). "Press Release: Kinaxo Enters Agreement with Bristol-Myers Squibb Company". Martinsried....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.